HomeCompareSIO vs JNJ

SIO vs JNJ: Dividend Comparison 2026

SIO yields 6.94% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SIO wins by $11.6K in total portfolio value
10 years
SIO
SIO
● Live price
6.94%
Share price
$25.63
Annual div
$1.78
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$1,078.32
Full SIO calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SIO vs JNJ

📍 SIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SIO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIO
Annual income on $10K today (after 15% tax)
$589.83/yr
After 10yr DRIP, annual income (after tax)
$916.57/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SIO beats the other by $212.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIO + JNJ for your $10,000?

SIO: 50%JNJ: 50%
100% JNJ50/50100% SIO
Portfolio after 10yr
$25.8K
Annual income
$953.05/yr
Blended yield
3.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SIO
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIO buys
0
JNJ buys
0
No recent congressional trades found for SIO or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIOJNJ
Forward yield6.94%3.36%
Annual dividend / share$1.78$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31.6K$20.0K
Annual income after 10y$1,078.32$827.78
Total dividends collected$8.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SIO vs JNJ ($10,000, DRIP)

YearSIO PortfolioSIO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,394$693.92$10,676$355.77+$718.00SIO
2$12,930$738.92$11,407$389.39+$1.5KSIO
3$14,619$783.70$12,198$426.53+$2.4KSIO
4$16,471$828.10$13,056$467.62+$3.4KSIO
5$18,496$871.94$13,987$513.12+$4.5KSIO
6$20,705$915.07$14,998$563.56+$5.7KSIO
7$23,112$957.39$16,098$619.52+$7.0KSIO
8$25,729$998.76$17,295$681.69+$8.4KSIO
9$28,569$1,039.10$18,599$750.82+$10.0KSIO
10$31,647$1,078.32$20,022$827.78+$11.6KSIO

SIO vs JNJ: Complete Analysis 2026

SIOStock

The fund invests, under normal market conditions, at least 80% of its assets in income producing fixed-income securities. In building the fund’s portfolio, it invests at least 50% of the fund's portfolio in investment-grade rated debt securities. It may also invest up to 50% of the fund's portfolio in non-investment-grade debt securities. It will generally sell a security if the price/yield no longer adequately compensates for the risk profile or if there is a change to allocation between sectors based on relative value.

Full SIO Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SIO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIO vs SCHDSIO vs JEPISIO vs OSIO vs KOSIO vs MAINSIO vs ABBVSIO vs MRKSIO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.